Biovance Capital Partners
ABOUT BIOVANCE CAPITAL PARTNERS
Biovance Capital Partners is a Lisbon venture capital firm founded in 2023 and described as Portugal's first specialised biotech VC. It invests at seed and Series A in early-stage drug-development companies across Europe, with a special emphasis on Southern Europe, writing tickets of €1.5M–€6M. Biovance Capital Fund I was launched in 2024 and reached €57M (against a €60M target) in June 2025 with BIAL's investment; other backers include the European Investment Fund (EIF), Banco Português de Fomento, the European Commission (Portugal Tech / InvestEU), Caixa Capital and Ageas Pensões. That mix gives the firm both pharma sector depth and institutional support. The team is led by Managing Partner Ricardo Perdigão Henriques, with General Partner João Incio, Principal André Albergaria and Non-Executive Partner Peter Villax. Having made two investments so far, its portfolio includes Laigo Bio (seed) and Mondego Bio (Series A, co-led with OrbiMed and Torrey Pines). Biovance targets companies with strong preclinical models and patented or patentable assets, using BIAL's expertise and EIF backing to support development.
INVESTMENT THESIS
Early-stage biopharma investor (seed and Series A) across Europe with a Southern Europe focus. Targets drug-development companies with strong preclinical models and patented or patentable assets. BIAL's pharma expertise and EIF backing give it sector depth.
INVESTMENT DETAILS
TEAM
FREQUENTLY ASKED QUESTIONS
What stage does Biovance Capital Partners invest at?
Biovance Capital Partners invests at Seed, Series A stages.
What is Biovance Capital Partners's typical ticket size?
Biovance Capital Partners typically writes cheques of €1.5M–€6M.
What sectors does Biovance Capital Partners invest in?
Biovance Capital Partners focuses on Life Sciences, Biotech.
Where is Biovance Capital Partners based?
Biovance Capital Partners is a VC based in Lisbon, Portugal, founded in 2023.
Who are the partners at Biovance Capital Partners?
Key people at Biovance Capital Partners include Ricardo Perdigão Henriques (Managing Partner), João Incio (General Partner), Peter Villax (Non-Executive Partner).
What companies has Biovance Capital Partners invested in?
Biovance Capital Partners's portfolio includes Laigo Bio, Mondego Bio.
How much does Biovance Capital Partners manage?
Biovance Capital Partners manages €57M in assets / fund commitments.
Is Biovance Capital Partners actively investing?
Fund I €57M (closed Jun 2025), deploying.
Can I invest in Biovance Capital Partners's funds as an external investor?
Biovance Capital Partners raises its funds from external investors (LPs). No open subscription window is publicly announced right now — prospective LPs are typically onboarded when the next fund is raised.
How do I contact or pitch Biovance Capital Partners?
You can reach Biovance Capital Partners via their website (biovancecapital.com). You can also run your startup through Portugal VC's AI matcher to get a ranked shortlist of the investors that fit.